145 related articles for article (PubMed ID: 10909897)
1. Procalcitonin and proinflammatory cytokine interactions in sepsis.
Whang KT; Vath SD; Becker KL; Snider RH; Nylen ES; Muller B; Li Q; Tamarkin L; White JC
Shock; 2000 Jul; 14(1):73-8. PubMed ID: 10909897
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin and proinflammatory cytokine in interactions in sepsis.
Whang KT; Vath SD; Becker KL; Snider RH; Nylen ES; Muller B; Li Q; Tamarkin L; White JC
Shock; 1999 Oct; 12(4):268-73. PubMed ID: 10509628
[TBL] [Abstract][Full Text] [Related]
3. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.
Nylen ES; Whang KT; Snider RH; Steinwald PM; White JC; Becker KL
Crit Care Med; 1998 Jun; 26(6):1001-6. PubMed ID: 9635646
[TBL] [Abstract][Full Text] [Related]
4. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis.
Martinez JM; Wagner KE; Snider RH; Nylen ES; Muller B; Sarani B; Becker KL; White JC
Surg Infect (Larchmt); 2001; 2(3):193-202; discussion 202-3. PubMed ID: 12593709
[TBL] [Abstract][Full Text] [Related]
5. Exogenous procalcitonin evokes a pro-inflammatory cytokine response.
Liappis AP; Gibbs KW; Nylen ES; Yoon B; Snider RH; Gao B; Becker KL
Inflamm Res; 2011 Feb; 60(2):203-7. PubMed ID: 20953970
[TBL] [Abstract][Full Text] [Related]
6. Immunoneutralization of procalcitonin as therapy of sepsis.
Becker KL; Nylén ES; Snider RH; Müller B; White JC
J Endotoxin Res; 2003; 9(6):367-74. PubMed ID: 14733723
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue.
Linscheid P; Seboek D; Nylen ES; Langer I; Schlatter M; Becker KL; Keller U; Müller B
Endocrinology; 2003 Dec; 144(12):5578-84. PubMed ID: 12960010
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization.
Snider RH; Nylen ES; Becker KL
J Investig Med; 1997 Dec; 45(9):552-60. PubMed ID: 9444882
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.
Becker KL; Snider R; Nylen ES
Crit Care Med; 2008 Mar; 36(3):941-52. PubMed ID: 18431284
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury.
Araujo M; Doi SQ; Palant CE; Nylen ES; Becker KL
Inflamm Res; 2013 Oct; 62(10):887-94. PubMed ID: 23872926
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator?
Dahaba AA; Metzler H
Minerva Anestesiol; 2009; 75(7-8):447-52. PubMed ID: 18987569
[TBL] [Abstract][Full Text] [Related]
12. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs.
Wagner KE; Martinez JM; Vath SD; Snider RH; Nylén ES; Becker KL; Müller B; White JC
Crit Care Med; 2002 Oct; 30(10):2313-21. PubMed ID: 12394961
[TBL] [Abstract][Full Text] [Related]
13. Immunoneutralization of procalcitonin or its component peptides: a promising treatment of sepsis.
Becker KL
Clin Sci (Lond); 2010 Dec; 119(12):515-7. PubMed ID: 20649514
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis.
Sexton PM; Christopoulos G; Christopoulos A; Nylen ES; Snider RH; Becker KL
Crit Care Med; 2008 May; 36(5):1637-40. PubMed ID: 18434892
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
Becker KL; Snider R; Nylen ES
Br J Pharmacol; 2010 Jan; 159(2):253-64. PubMed ID: 20002097
[TBL] [Abstract][Full Text] [Related]
16. Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies.
Tavares E; Miñano FJ
Clin Sci (Lond); 2010 Dec; 119(12):519-34. PubMed ID: 20569200
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1.
Gérard Y; Hober D; Assicot M; Alfandari S; Ajana F; Bourez JM; Chidiac C; Mouton Y; Bohuon C; Wattre P
J Infect; 1997 Jul; 35(1):41-6. PubMed ID: 9279723
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin is not produced by circulating blood cells.
Monneret G; Laroche B; Bienvenu J
Infection; 1999; 27(1):34-5. PubMed ID: 10027104
[TBL] [Abstract][Full Text] [Related]
19. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
Ittner L; Born W; Rau B; Steinbach G; Fischer JA
Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
[TBL] [Abstract][Full Text] [Related]
20. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue.
Linscheid P; Seboek D; Zulewski H; Keller U; Müller B
Endocrinology; 2005 Jun; 146(6):2699-708. PubMed ID: 15761041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
